Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Radius Heal stock

Learn how to easily invest in Radius Heal stock.

Radius Heal
NASDAQ: RDUS - USD
$10.40
- $0.08 ( - 0.76%)
DRUG MANUFACTURERS-SPECIALTY & GENERIC

Radius Heal is a drug manufacturers-specialty & generic business based in the US. Radius Heal shares (RDUS) are listed on the NASDAQ and all prices are listed in US Dollars. Radius Heal employs 293 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Radius Heal

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – RDUS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Radius Heal stock price (NASDAQ: RDUS)

Use our graph to track the performance of RDUS stocks over time.

Radius Heal shares at a glance

Information last updated 2022-07-01.
Latest market close$10.48
52-week range$4.97 - $23.00
50-day moving average $7.17
200-day moving average $10.11
Wall St. target price$9.60
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.54

Buy Radius Heal shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Radius Heal stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Radius Heal price performance over time

Historical closes compared with the close of $10.48 from 2022-07-01

1 week (2022-06-28) -0.19%
1 month (2022-06-01) N/A
3 months (2022-04-05) 20.18%
6 months (2022-01-05) 67.41%
1 year (2021-07-02) -41.29%
2 years (2020-07-02) -26.04%
3 years (2019-07-05) 24.62
5 years (2017-07-03) 45.95

Radius Heal financials

Revenue TTM $216.9 million
Gross profit TTM $211.6 million
Return on assets TTM -17.8%
Return on equity TTM 0%
Profit margin -33.52%
Book value $0.00
Market capitalisation $493.6 million

TTM: trailing 12 months

Radius Heal share dividends

We're not expecting Radius Heal to pay a dividend over the next 12 months.

Have Radius Heal's shares ever split?

Radius Heal's shares were split on a 25:57 basis on 23 April 2014. So if you had owned 57 shares the day before before the split, the next day you'd have owned 25 shares. This wouldn't directly have changed the overall worth of your Radius Heal shares – just the quantity. However, indirectly, the new 128% higher share price could have impacted the market appetite for Radius Heal shares which in turn could have impacted Radius Heal's share price.

Radius Heal share price volatility

Over the last 12 months, Radius Heal's shares have ranged in value from as little as $4.97 up to $23. A popular way to gauge a stock's volatility is its "beta".

RDUS.US volatility(beta: 1.03)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Radius Heal's is 1.0336. This would suggest that Radius Heal's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Radius Heal overview

Radius Health, Inc. , a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd. ; and Duke University.

Frequently asked questions

What percentage of Radius Heal is owned by insiders or institutions?
Currently 0.525% of Radius Heal shares are held by insiders and 117.335% by institutions.
How many people work for Radius Heal?
Latest data suggests 293 work at Radius Heal.
When does the fiscal year end for Radius Heal?
Radius Heal's fiscal year ends in December.
Where is Radius Heal based?
Radius Heal's address is: 22 Boston Wharf Road, Boston, MA, United States, 02210
What is Radius Heal's ISIN number?
Radius Heal's international securities identification number is: US7504692077
What is Radius Heal's CUSIP number?
Radius Heal's Committee on Uniform Securities Identification Procedures number is: 750469207

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site